H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Atomic-level computer model of the H1N1 virus reveals new vulnerabilities

Atomic-level computer model of the H1N1 virus reveals new vulnerabilities

Breathing and tilting motions of influenza glycoproteins could be exploited to better defend against flu

Breathing and tilting motions of influenza glycoproteins could be exploited to better defend against flu

Recent progress in the understanding of neuraminidase-specific antibodies for the development of universal influenza vaccines

Recent progress in the understanding of neuraminidase-specific antibodies for the development of universal influenza vaccines

World Health Organization reports insufficient evidence to support syndromic screening for COVID-19

World Health Organization reports insufficient evidence to support syndromic screening for COVID-19

Seasonal influenza activity remains high but appears to be declining in some areas of the US

Seasonal influenza activity remains high but appears to be declining in some areas of the US

First H5N3 infection in a captive emperor tamarin documented in new study

First H5N3 infection in a captive emperor tamarin documented in new study

Natural substances show great therapeutic potential to inhibit influenza viruses

Natural substances show great therapeutic potential to inhibit influenza viruses

Much of the CDC is working remotely. That could make changing the agency difficult.

Much of the CDC is working remotely. That could make changing the agency difficult.

Could mRNA vaccines triumph over other viral infections in humans and domestic animals?

Could mRNA vaccines triumph over other viral infections in humans and domestic animals?

Human case of swine-origin influenza A virus detected in Denmark, according to CDC study

Human case of swine-origin influenza A virus detected in Denmark, according to CDC study

WHO releases new data on worldwide influenza activity

WHO releases new data on worldwide influenza activity

Research sheds light on cardiac pathology mechanisms of COVID-19

Research sheds light on cardiac pathology mechanisms of COVID-19

Hemagglutinin stem immunogens may hold the key for broad protection against influenza A viruses

Hemagglutinin stem immunogens may hold the key for broad protection against influenza A viruses

Coronavirus exposure reduction strategies in aircraft cabins involving vacant middle seats and masks

Coronavirus exposure reduction strategies in aircraft cabins involving vacant middle seats and masks

Skipping methotrexate for one week after flu vaccine provides the same seroprotection as a two-week hold in RA patients

Skipping methotrexate for one week after flu vaccine provides the same seroprotection as a two-week hold in RA patients

Influenza hospitalizations at highest level in ten years, predicting a severe U.S. flu season

Influenza hospitalizations at highest level in ten years, predicting a severe U.S. flu season

Hybrid virus particles formed from coinfections exhibit immune evasion and expanded tropism

Hybrid virus particles formed from coinfections exhibit immune evasion and expanded tropism

A review of emerging pediatric respiratory viruses

A review of emerging pediatric respiratory viruses

Exploring molecular docking and molecular dynamics simulations as advanced tools for novel antiviral drug discovery

Exploring molecular docking and molecular dynamics simulations as advanced tools for novel antiviral drug discovery

Inhalation therapeutics against COVID-19

Inhalation therapeutics against COVID-19